We are a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors.
$10.50 - $12.50
December 15, 2021
ROTH CAPITAL PARTNERS, LLC
This offering is no longer available
Sign Up to participate in future offerings
To view the prospectus for Genenta Science IPO, or any offering listed on ClickIPO,
download the ClickIPO app...
or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277